SGLT2 Inhibition in the Diabetic Kidney—From Mechanisms to Clinical Outcome | American Society of Nephrology
Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors - Yakovleva -
SGLT2 Inhibitors: A Review of Canagliflozin
Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research | Diabetes
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure | Heart
Canagliflozin - an overview | ScienceDirect Topics
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors - Kidney International
A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium‐glucose co‐transporter‐2 inhibitors - Brown - 2019 - Diabetes, Obesity and Metabolism - Wiley Online Library
SGLT-2 inhibitors in diabetes: a focus on renoprotection
Ueda2015 canagliflozin dr.inass shaltout
SGLT2 inhibitors for treatment of Type 2 diabetes mellitus: Focus on Canagliflozin Singh SK, Gupta A K - Muller J Med Sci Res
Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features ...
![canagliflozin [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/sglt2.png "canagliflozin [TUSOM | Pharmwiki]")
canagliflozin [TUSOM | Pharmwiki]
Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways | Scientific Reports
ERA-EDTA on Twitter: "Mechanism of action #canagliflozin #eraedta19… "
Introduction to SGLT2 Inhibition - YouTube
Swiss Medical Weekly - Use of SGLT2 inhibitors in cardiovascular diseases: why, when and how?
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation - American Journal of Kidney Diseases
Top 10 Things Invokana Patients Need To Know... - Childers, Schlueter & Smith, LLC
Mode of action of SGLT2 inhibitors in the kidney. Copied with... | Download Scientific Diagram
Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes | Clinical Diabetes
SGLT2 Inhibitors: A New Class of Diabetes Medications
Update on Mx of T 2 DM Emerging
SGLT2 inhibitors
SGLT 2 inhibitors
